NCT03205020

Brief Summary

The aim of the current study is to assess the accuracy of maternal serum amyloid A for prediction of preterm labor in women with threatened preterm labor.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
58

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 13, 2017

Completed
18 days until next milestone

Study Start

First participant enrolled

July 1, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 2, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2018

Completed
Last Updated

July 5, 2017

Status Verified

June 1, 2017

Enrollment Period

6 months

First QC Date

June 13, 2017

Last Update Submit

June 30, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • prevalence of Amyloid A level in women with preterm labour

    venous sample will be taken from each participant from onset of labour, Amyloid a level will be calculated

    6 months

Secondary Outcomes (1)

  • neonatal complications

    6 months

Study Arms (2)

women with preterm labor

Diagnostic Test: serum amyloid a test

women delivered at full term

Diagnostic Test: serum amyloid a test

Interventions

serum amyloid a testDIAGNOSTIC_TEST

* Women who are diagnosed with preterm labor (28-36 weeks) will be enrolled in this study. Serum samples will be collected from all women before any intervention. All women will be sampled once at the time of admission. * Venous blood sample (5 c.c) will be taken from each participant for examination of serum amyloid A. * The collected blood will be centrifuging and serum will be stored to measure the level of amyloid A by (ELISA) technique in clinical pathology department- Ain shams University

women delivered at full termwomen with preterm labor

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

58 pregnant women will be recruited

You may qualify if:

  • Pregnant women, age 18 - 35.
  • Gestational age: 28 - 36+6 weeks.
  • Singleton pregnancy.
  • No past history of any medical disorder and with no other medical complications during pregnancy
  • Nonsmoker.
  • Diagnosis of preterm labor is based on the American College of Obstetricians and Gynecologists Guidelines
  • Criteria of preterm delivery:
  • Gestational age: 28 - 36+6 weeks
  • Presence of uterine contractions (at least 4 in 20 minutes or 8 in 60 minutes)
  • cervical dilation ≥ 4 cm
  • Cervical effacement ≥ 80%.

You may not qualify if:

  • Of any patient with the following risk factors for preterm labor:
  • Over distended uterus .
  • hemorrhage
  • Uterine anomalies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams University

Cairo, Egypt

RECRUITING

MeSH Terms

Conditions

Obstetric Labor, Premature

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • mona mohamed, MS

    Ain Shams University

    STUDY CHAIR

Central Study Contacts

mona cairo nematallah, MS

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
physician

Study Record Dates

First Submitted

June 13, 2017

First Posted

July 2, 2017

Study Start

July 1, 2017

Primary Completion

January 1, 2018

Study Completion

February 1, 2018

Last Updated

July 5, 2017

Record last verified: 2017-06

Locations